-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on AbbVie, Raises Price Target to $300

Benzinga·08/17/2026 13:04:29
Listen to the news
Wells Fargo analyst Mohit Bansal maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $295 to $300.